flâneur

新冠疫苗再添生力軍！賽諾菲/GSK 疫苗二期呈「強烈免疫反應」 | TechNews 科技新報

technews.tw · 673 words · saved by 1 readers

法國藥廠賽諾菲（Sanofi）與英國葛蘭素史克藥廠（GSK）今日發表報告指出，雙方共同研發的新冠肺炎（COVID-19）疫苗在第二期臨床試驗呈現「強烈免疫反應」，預計將在未來幾週啟動第三期臨床試驗，代表又有一支新冠疫苗可望加入抗疫行列，目標今年第 4 季可以獲批上市。 賽諾菲和葛蘭素史...

in window ) msGesture window.DocumentTouch && document instanceof DocumentTouch) && slider.vars.touch, // depricating this idea, as devices are being released with both of these events eventType = ) slider.controlsContainer = $(slider.vars.controlsContainer).length > 0 && $(slider.vars.controlsContainer); // MANUAL: if (slider.vars.manualControls !== ) slider.manualControls = $(slider.vars.manualControls).length > 0 && $(slider.vars.manualControls); // CUSTOM DIRECTION NAV: if (slider.vars.customDirectionNav !== ) { slideString = (reverse) ? 0 : (slider.count + 1) * dimension; } else { slideSt

related reading